Randy Berholtz, J.D.
- Mr. Berholtz is a Sr. Fund Advisor and Fund Counsel with Mesa Verde and a Member of the Investment Committee. Mr. Berholtz has over 24 years experience as a venture capital, securities, private and public financing, mergers and acquisitions, intellectual property, intellectual property litigation and regulatory lawyer in the life sciences including over 14 years as the general counsel to three public life science companies in San Diego (Nanogen, Inc., Apricus Biosciences, Inc., and Innovus Pharmaceuticals, Inc.) and to one group of US and Chinese life science companies in San Diego and Hangzhou, China (the ACON Group). He has also served as the Chief Operating Officer and General Counsel to IngleWood Ventures, L.P. and has held roles as a general partner, venture partner, advisor and consultant to a number of life science venture capital firms. He was also a member of the San Diego Tech Coast Angels (BioMedTRak Group) and the Life Science Angels. He is currently on the Board of Directors of Strategic Drug Solutions, Inc., the first spin-out company from the Western University of Health Sciences in Pomona, California and has been on the board of directors of four other life science companies. He is a past Adjunct Professor at the Keck Graduate Institute of Applied Life Sciences at the Claremont Colleges and a past Lecturer at the Rady School of Business at the University of California, San Diego. Randy has his BA from Cornell University in political economy, his M.Litt from Oxford University where he was a Rhodes Scholar, his J.D. from the Yale Law School and is expected to receive his MBA (2016) from the University of San Diego.